UK tech transfer company signs licensing deal for Phase II endocrine product
This article was originally published in Scrip
Fusion IP, which owns the rights to intellectual property generated at two UK universities – the University of Sheffield and Cardiff University, has signed a licensing deal with a pharmaceutical company utilising IP out of the University of Sheffield. Further details are being withheld for commercial reasons. The licence covers development of a known drug, in the area of certain endocrine diseases, in a market worth over $500 million per annum.